Page 52 - Pli News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Pli. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Read more about Govt gives approval to four firms under PLI scheme for bulk drugs on Business Standard. The government has given approval to four waitlisted firms under the Production Linked Incentive (PLI) scheme for domestic manufacturing of bulk drugs, an official statement said on Monday.The Department of Pharmaceuticals had launched the PLI ....
India Business News: The government has given approval to four waitlisted firms under the production linked incentive (PLI) scheme for domestic manufacturing of bulk drugs ....
PIL scheme: Govt approves four applications for KSMs/drug intermediaries, APIs May 31, 2021 Forty six applications with committed investment of ₹5,355.44 crore have been approved so far The government, on Monday, approved four applications under its production-linked scheme for promotion of the domestic manufacturing of Key Starting Materials (KSMs)/ Drug Intermediates and Active Pharmaceutical Ingredients (APIs). According to a Chemicals and Fertilizers Ministry statement, Solara Active Pharma Science Limited received approval for 1,1 Cyclohexane Diacetic Acid (CDA) under the chemical synthesis-based KSMs/Drug Intermediates segment, and Rajasthan Antibiotics Ltd received nod for Meropenem Other Chemical Synthesis Based KSMs/Drug Intermediates and APIs. Similarly, Dhatri Lab Private Ltd has received approval for Ritonavir and Vital Laboratories Private Ltd for Levofloxacin under the segment of Other Chemical Synthesis-based KSMs/Drug Intermediates and APIs. T ....
All the 215 applications received for the 36 products spread across the four target segments were considered and appraised and selected participants duly informed, the Ministry of Chemicals and Fertilizers said. ....
The stock also did not react much, ending the day flat on Friday. Analysts said new opportunities are likely going forward for this one of the biggest beneficiaries of the government s Atmanirbhar Bharat initiative. They are also projecting a 70-80 per cent growth in earnings for this electronic manufacturer over FY21-23. But after an 8 times surge in the stock price over the last two years, they have a wide target range of Rs 3,850-4,800 for the stock. Nirmal Bang finds the stock Rs 3,850 worthy. YES Securities sees the scrip at Rs 4,350. Emkay Global has a target of Rs 4,500 on the stock. Sharekhan has a target of Rs 4,800 on the stock, but on FY24 earnings estimates. ....